UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells

The Journal of immunology (1950), 2010-08, Vol.185 (4), p.2273-2284

2010

Volltextzugriff (PDF)

A New Twist on a Classic: Enhancing Radioiodine Uptake in Advanced Thyroid Cancer

Clinical cancer research, 2024-04, Vol.30 (7), p.1220-1222

2024

Volltextzugriff (PDF)

Insights into immune checkpoint inhibitor-induced thyroiditis

Nature reviews. Endocrinology, 2021-11, Vol.17 (11), p.643-644

2021

Volltextzugriff (PDF)

Anaplastic Large Cell Lymphoma Occurring in Women with Breast Implants: Analysis of 173 Cases

Plastic and reconstructive surgery (1963), 2015-03, Vol.135 (3), p.695-705

2015

Volltextzugriff (PDF)

Functional characterization of human Cd33+ and Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines

Journal of translational medicine, 2011-06, Vol.9 (1), p.90-90, Article 90

2011

Volltextzugriff (PDF)

Immunogenicity of murine solid tumor models as a defining feature of in vivo behavior and response to immunotherapy

Journal of immunotherapy (1997), 2013-11, Vol.36 (9), p.477-489

2013

Volltextzugriff (PDF)

Optimal Thyroid Hormone Replacement Dose in Immune Checkpoint Inhibitor-Associated Hypothyroidism Is Distinct from Hashimoto's Thyroiditis

Thyroid (New York, N.Y.), 2022-05, Vol.32 (5), p.496-504

2022

Volltextzugriff (PDF)

Polyendocrine Autoimmunity and Diabetic Ketoacidosis Following Anti-PD-1 and Interferon α

Pediatrics (Evanston), 2022-04, Vol.149 (4), p.1

2022

Volltextzugriff (PDF)

MHC class I loss is a frequent mechanism of immune escape in papillary thyroid cancer that is reversed by interferon and selumetinib treatment in vitro

Clinical cancer research, 2014-12, Vol.20 (23), p.6034-6044

2014

Volltextzugriff (PDF)

The Combined Effect of Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors on Thyroid Function

Thyroid (New York, N.Y.), 2024-02, Vol.34 (2), p.158

2024

Volltextzugriff (PDF)

Antigen presentation by clonally diverse CXCR5+ B cells to CD4 and CD8 T cells is associated with durable response to immune checkpoint inhibitors

Frontiers in immunology, 2023-06, Vol.14, p.1176994-1176994

2023

Volltextzugriff (PDF)

A pathologically expanded, clonal lineage of IL-21–producing CD4+ T cells drives inflammatory neuropathy

The Journal of clinical investigation, 2024-08, Vol.134 (15), p.1-13

2024

Volltextzugriff (PDF)

Clinical Features and Hospital Outcomes in Thyroid Storm: A Retrospective Cohort Study

The journal of clinical endocrinology and metabolism, 2015-02, Vol.100 (2), p.451-459

2015

Volltextzugriff (PDF)

Survival Signals and Targets for Therapy in Breast Implant― Associated ALK― Anaplastic Large Cell Lymphoma

Clinical cancer research, 2012-09, Vol.18 (17), p.4549-4559

2012

Volltextzugriff (PDF)

Risk Factors for New Hypothyroidism During Tyrosine Kinase Inhibitor Therapy in Advanced Nonthyroidal Cancer Patients

Thyroid (New York, N.Y.), 2018-04, Vol.28 (4), p.437-444

2018

Volltextzugriff (PDF)

Inhibition of IL-17A Protects against Thyroid Immune-Related Adverse Events while Preserving Checkpoint Inhibitor Antitumor Efficacy

The Journal of immunology (1950), 2022-08, Vol.209 (4), p.696-709

2022

Volltextzugriff (PDF)

Clonally expanded, thyrotoxic effector CD8 + T cells driven by IL-21 contribute to checkpoint inhibitor thyroiditis

Science translational medicine, 2023-05, Vol.15 (696), p.eadg0675

2023

Volltextzugriff (PDF)

Pathogenic TNF-α drives peripheral nerve inflammation in an Aire-deficient model of autoimmunity

Proceedings of the National Academy of Sciences - PNAS, 2022-01, Vol.119 (4), p.1

2022

Volltextzugriff (PDF)

Changes in Stage Distribution and Disease‐Specific Survival in Differentiated Thyroid Cancer with Transition to American Joint Committee on Cancer 8th Edition: A Systematic Review and Meta‐Analysis

The oncologist (Dayton, Ohio), 2021-02, Vol.26 (2), p.e251-e260

2021

Volltextzugriff (PDF)

Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium

Journal of clinical oncology, 2023-07, Vol.41 (21), p.3712-3723

2023

Volltextzugriff (PDF)

Prognostic Value of Preoperative Molecular Testing and Implications for Initial Surgical Management in Thyroid Nodules Harboring Suspected (Bethesda V) or Known (Bethesda VI) Papillary Thyroid Cancer

JAMA otolaryngology-- head & neck surgery, 2023-08, Vol.149 (8), p.735

2023

Volltextzugriff (PDF)

Circulating Myeloid-Derived Suppressor Cells Predict Differentiated Thyroid Cancer Diagnosis and Extent

Thyroid (New York, N.Y.), 2016-03, Vol.26 (3), p.381-389

2016

Volltextzugriff (PDF)

Safety and efficacy of immune checkpoint inhibitor cancer therapy in patients with preexisting type 1 diabetes mellitus

Frontiers in endocrinology (Lausanne), 2023, Vol.14, p.1242830-1242830

2023

Volltextzugriff (PDF)

Frequency of Thyroid Hormone Replacement After Lobectomy for Differentiated Thyroid Cancer

Endocrine practice, 2021-07, Vol.27 (7), p.691-697

2021

Volltextzugriff (PDF)

COVID-19 Outcomes of Patients With Differentiated Thyroid Cancer: A Multicenter Los Angeles Cohort Study

Endocrine practice, 2021-02, Vol.27 (2), p.90-94

2021

Volltextzugriff (PDF)

1 – 25 von 125

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(115)
Mit Volltextzugriff
(96)

Publikationsform

Sprache

Englisch
(124)
Japanisch
(10)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Characterization of cytokine-induced myeloid-derived suppressor cells from normal human peripheral blood mononuclear cells

A New Twist on a Classic: Enhancing Radioiodine Uptake in Advanced Thyroid Cancer

Insights into immune checkpoint inhibitor-induced thyroiditis

Anaplastic Large Cell Lymphoma Occurring in Women with Breast Implants: Analysis of 173 Cases

Functional characterization of human Cd33+ and Cd11b+ myeloid-derived suppressor cell subsets induced from peripheral blood mononuclear cells co-cultured with a diverse set of human tumor cell lines

Immunogenicity of murine solid tumor models as a defining feature of in vivo behavior and response to immunotherapy

Optimal Thyroid Hormone Replacement Dose in Immune Checkpoint Inhibitor-Associated Hypothyroidism Is Distinct from Hashimoto's Thyroiditis

Polyendocrine Autoimmunity and Diabetic Ketoacidosis Following Anti-PD-1 and Interferon α

MHC class I loss is a frequent mechanism of immune escape in papillary thyroid cancer that is reversed by interferon and selumetinib treatment in vitro

The Combined Effect of Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors on Thyroid Function

Antigen presentation by clonally diverse CXCR5+ B cells to CD4 and CD8 T cells is associated with durable response to immune checkpoint inhibitors

A pathologically expanded, clonal lineage of IL-21–producing CD4+ T cells drives inflammatory neuropathy

Clinical Features and Hospital Outcomes in Thyroid Storm: A Retrospective Cohort Study

Survival Signals and Targets for Therapy in Breast Implant― Associated ALK― Anaplastic Large Cell Lymphoma

Risk Factors for New Hypothyroidism During Tyrosine Kinase Inhibitor Therapy in Advanced Nonthyroidal Cancer Patients

Inhibition of IL-17A Protects against Thyroid Immune-Related Adverse Events while Preserving Checkpoint Inhibitor Antitumor Efficacy

Clonally expanded, thyrotoxic effector CD8 + T cells driven by IL-21 contribute to checkpoint inhibitor thyroiditis

Pathogenic TNF-α drives peripheral nerve inflammation in an Aire-deficient model of autoimmunity

Changes in Stage Distribution and Disease‐Specific Survival in Differentiated Thyroid Cancer with Transition to American Joint Committee on Cancer 8th Edition: A Systematic Review and Meta‐Analysis

Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium

Prognostic Value of Preoperative Molecular Testing and Implications for Initial Surgical Management in Thyroid Nodules Harboring Suspected (Bethesda V) or Known (Bethesda VI) Papillary Thyroid Cancer

Circulating Myeloid-Derived Suppressor Cells Predict Differentiated Thyroid Cancer Diagnosis and Extent

Safety and efficacy of immune checkpoint inhibitor cancer therapy in patients with preexisting type 1 diabetes mellitus

Frequency of Thyroid Hormone Replacement After Lobectomy for Differentiated Thyroid Cancer

COVID-19 Outcomes of Patients With Differentiated Thyroid Cancer: A Multicenter Los Angeles Cohort Study

Suchergebnisse filtern